Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
about
Is cognitive functioning impaired in methamphetamine users? A critical reviewMethamphetamine inhibits antigen processing, presentation, and phagocytosisImpact of methamphetamine on infection and immunitySerial analysis of gene expression in the rat striatum following methamphetamine administrationAge-dependent effects of neonatal methamphetamine exposure on spatial learning.Methamphetamine-induced deficits in social interaction are not observed following abstinence from single or repeated exposures.Comparison of time-dependent effects of (+)-methamphetamine or forced swim on monoamines, corticosterone, glucose, creatine, and creatinine in ratsSingle and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum.Alterations in the striatal dopamine system during intravenous methamphetamine exposure: effects of contingent and noncontingent administration.Methamphetamine reduces LTP and increases baseline synaptic transmission in the CA1 region of mouse hippocampus.3,4-Methylenedioxymethamphetamine in adult rats produces deficits in path integration and spatial reference memory.Alterations in body temperature, corticosterone, and behavior following the administration of 5-methoxy-diisopropyltryptamine ('foxy') to adult rats: a new drug of abuse.The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access.Amphetamine-induced release of dopamine in primate prefrontal cortex and striatum: striking differences in magnitude and timecourseThe relationship between methamphetamine and alcohol use in a community sample of methamphetamine users.Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.Reversal of long-term methamphetamine sensitization by combination of pergolide with ondansetron or ketanserin, but not mirtazapine.Acute and residual interactive effects of repeated administrations of oral methamphetamine and alcohol in humansA direct comparison of the behavioral and physiological effects of methamphetamine and 3,4-methylenedioxymethamphetamine (MDMA) in humans.Methamphetamine Use in HIV-infected Individuals Affects T-cell Function and Viral Outcome during Suppressive Antiretroviral Therapy.Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cellsAcute modafinil exposure reduces daytime sleepiness in abstinent methamphetamine-dependent volunteersMethamphetamine Alters the Antimicrobial Efficacy of Phagocytic Cells during Methicillin-Resistant Staphylococcus aureus Skin Infection.Residual effects of intranasal methamphetamine on sleep, mood, and performance.Development of stereotyped behaviors during prolonged escalation of methamphetamine self-administration in rats.Effect of +-methamphetamine on path integration learning, novel object recognition, and neurotoxicity in ratsAcute physiological and behavioral effects of intranasal methamphetamine in humans.Methamphetamine exposure antagonizes N-methyl-D-aspartate receptor-mediated neurotoxicity in organotypic hippocampal slice cultures.(+/-)-3,4-Methylenedioxymethamphetamine treatment in adult rats impairs path integration learning: a comparison of single vs once per week treatment for 5 weeks.Exercise protects against methamphetamine-induced aberrant neurogenesis.Bioavailability of (+)-methamphetamine in the pigeon following an intramuscular dose.A Mouse Model for Binge-Level Methamphetamine Use.Functional and biological determinants affecting the duration of action and efficacy of anti-(+)-methamphetamine monoclonal antibodies in rats.Effects of methamphetamine abuse beyond individual users.Characterization of the guinea pig animal model and subsequent comparison of the behavioral effects of selective dopaminergic drugs and methamphetamine.Neurobehavioral Effects from Developmental Methamphetamine Exposure.Chronic Exposure to Methamphetamine Disrupts Reinforcement-Based Decision-Making in Rats.Mechanisms involved in the neurotoxic and cognitive effects of developmental methamphetamine exposure.Methamphetamine alters occludin expression via NADPH oxidase-induced oxidative insult and intact caveolae.Changes in leptin, ghrelin, growth hormone and neuropeptide-Y after an acute model of MDMA and methamphetamine exposure in rats.
P2860
Q24606455-FCB1CF6D-AD1C-4DE9-8D34-F1115657FA28Q24647304-E8F0F0B8-ACC9-40B7-A8CA-DFDE023F0867Q26829217-5B3C2D4D-C7CE-4C70-B2CF-14E70BF9E9E2Q28574873-1C892496-DE5E-4D7F-9891-7A59D2BF01ADQ28751397-BC00990B-C72C-4DB3-9919-B37A1FABCDCEQ30672716-DCF68B66-9AED-4E38-A756-8AAC3FE7B7F0Q33339006-6DB5FC4E-37AC-4F56-B7FB-46E1AE267959Q33580523-5B84F9B7-F0DA-4C15-99DE-FCAB01C9E06DQ33602644-9E741DED-CA10-4DF6-8CA5-51947377E057Q33627747-6AB92821-461B-46C8-A29B-95217DE996EFQ33923834-23737AC3-7FA5-4438-A960-2759BF1DC7A2Q33941234-13D8CF50-8629-43D5-881F-2D291B913958Q33992366-A0299D08-B4F4-47FD-94AB-9549475365FEQ34021079-2C32BB96-C49B-4A0D-AE21-734D684F7076Q34149087-1857D117-35C4-461B-964B-7DE256AEFFBAQ34256300-78FFE690-A07B-4EBF-AE39-43FB498AF1DBQ35040501-036650B5-1294-48E0-9278-BA3DC48C5AE3Q35563348-DECCFFC8-7375-4654-AB5F-A757C11FC0DBQ35604001-99BA1401-1B6E-4DA6-9597-C68D89E8C082Q35990287-CB5EF3DE-FA35-4341-8A9A-6625BC1AB4ADQ36062886-86453084-5053-4F70-A646-DFF2FD1BAF76Q36139962-A5C80E70-19F9-4CF6-9E0A-C355338AE45FQ36227306-C719AB1E-D59C-46E0-82B1-A654F86605E5Q36496674-6007717C-414A-4B47-9230-6EDC89722879Q36650613-5A83AB79-0FD6-4E40-91D4-2B425FAE226CQ36924648-36805FD5-9C66-4475-8AA5-06DD1EDD2A9AQ37032872-E6E54F7F-3265-4B8D-ADD5-1DC438655A3FQ37107605-E6B12CA0-EF27-4250-9F3B-43E8BCDC14B5Q37244754-7FB5FA21-D376-4760-9777-5990382EBF62Q37291367-8F06A733-6349-484A-9887-AEB442A077B2Q37330644-0050E62C-08F0-4E77-9F11-4FB0A2F56C69Q37385658-BE57F48D-4D59-486D-A4A8-675C9EDA0123Q37473928-A7B306AD-C50A-48DC-A081-DCDFA63C8478Q37649900-B6A94EF3-37E7-4642-9176-C5EBE0CAF57AQ37693604-73DEC769-0028-4882-A7CE-856078CD4AE5Q38621196-306ABF47-1C6E-4E75-AD55-B4D6C8B2DA10Q38662845-42DB0FC0-E215-4D7E-B973-AAF4D49FDA7DQ38864093-52673B15-689E-4AEB-9891-DFD52D5500A6Q39571251-7520DAFE-5213-49A5-821C-31EE79D118C9Q40168155-7298FBD0-ADB4-46D3-8E44-8FB7A2F96B0A
P2860
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
description
2001 nî lūn-bûn
@nan
2001 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
@ast
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
@en
type
label
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
@ast
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
@en
prefLabel
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
@ast
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
@en
P2093
P2860
P1433
P1476
Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse.
@en
P2093
P2860
P304
P356
10.1002/1098-2396(200102)39:2<161::AID-SYN7>3.0.CO;2-E
P577
2001-02-01T00:00:00Z